Preventive therapy for latent tuberculosis infection—the promise and the challenges
Around one third of the world's population may harbour latent tuberculosis infection (LTBI), an asymptomatic immunological state that confers a heightened risk of subsequently developing tuberculosis (TB). Effectively treating LTBI will be essential if the End TB Strategy is to be realized. Thi...
Main Authors: | G.J. Fox, C.C. Dobler, B.J. Marais, J.T. Denholm |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-03-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971216312231 |
Similar Items
-
Response to: Socio-political prescriptions for latent tuberculosis infection are required to prevent reactivation of tuberculosis
by: Greg J. Fox, et al.
Published: (2017-05-01) -
Outcomes of latent tuberculosis infection treatment in Istanbul
by: Abdullah Emre Güner, et al.
Published: (2022-01-01) -
Latent Tuberculosis: A Promising New Compound to Treat Non-Replicating and Intramacrophagic Mycobacteria
by: Débora Leite Campos, et al.
Published: (2022-09-01) -
Latent tuberculosis infection in the Polish prison staff
by: Aneta Filipek-Czerska, et al.
Published: (2021-08-01) -
Cytokine Biosignature of Active and Latent Mycobacterium Tuberculosis Infection in Children
by: Magdalena Druszczynska, et al.
Published: (2021-04-01)